Suppr超能文献

验证通过简化阴性和阳性症状访谈获得的六项目正负症状量表在门诊精神分裂症患者中的评分。

Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia.

机构信息

Psychosis Research Unit, Aarhus University Hospital-Psychiatry, Aarhus, Denmark.

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

出版信息

J Psychopharmacol. 2022 Nov;36(11):1208-1217. doi: 10.1177/02698811221131992. Epub 2022 Oct 21.

Abstract

BACKGROUND

The six-item Positive and Negative Syndrome Scale (PANSS-6) is a measure of the severity of core symptoms of schizophrenia, which can be administered via the brief Simplified Negative and Positive Symptoms Interview (SNAPSI). A recent study has confirmed the validity of PANSS-6 ratings as derived by SNAPSI (PANSS-6) among inpatients with schizophrenia.

AIMS

We aimed to test the validity of PANSS-6 among outpatients with schizophrenia using PANSS-6 ratings extracted from the 30-item PANSS-30 as derived by the Structured Clinical Interview for the Positive and Negative Syndrome Scale (PANSS-6) as a gold standard reference.

METHODS

PANSS-6 and PANSS-6 ratings were obtained at two time points by independent raters with established inter-rater reliability. Agreement between PANSS-6 and PANSS-6 ratings was estimated via intra-class coefficients (ICCs) and responsiveness over time was quantified using Spearman's rank correlation coefficients. Post hoc "leave-one-out" analyses were carried out, in which each rater in turn was excluded from the ICC calculations.

RESULTS

Seventy-three outpatients with schizophrenia participated in the study (mean age: 38.3 years; 56% males). The ICC for PANSS-6 versus PANSS-6 was 0.67 [95%CI = 0.56-0.76] and the Spearman's rank correlation coefficient for responsiveness was 0.40 ( = 0.004). When data from a specific outlying rater were excluded, the ICC for PANSS-6 versus PANSS-6 was 0.75 [95% CI = 0.63-0.83] and the Spearman's rank correlation coefficient for responsiveness was 0.55 ( = 0.018).

CONCLUSIONS

We found PANSS-6 ratings to have acceptable clinical validity, suggesting that PANSS-6 can be used for both inpatients and outpatients with schizophrenia.

摘要

背景

六项目阳性和阴性症状量表(PANSS-6)是一种衡量精神分裂症核心症状严重程度的量表,可以通过简化的阴性和阳性症状访谈(SNAPSI)进行管理。最近的一项研究证实了通过 SNAPSI(PANSS-6)得出的 PANSS-6 评分在住院精神分裂症患者中的有效性。

目的

我们旨在通过使用结构化临床访谈阳性和阴性综合征量表(PANSS-6)作为金标准参考,从 30 项 PANSS-30 中提取 PANSS-6 评分,来测试门诊精神分裂症患者中 PANSS-6 的有效性。

方法

由两位具有既定组内信度的独立评估者在两个时间点获得 PANSS-6 和 PANSS-6 评分。通过组内相关系数(ICC)评估 PANSS-6 与 PANSS-6 评分之间的一致性,并使用 Spearman 等级相关系数来量化随时间的反应性。进行事后“逐一剔除”分析,其中每个评估者依次从 ICC 计算中剔除。

结果

73 名门诊精神分裂症患者参与了研究(平均年龄:38.3 岁;56%为男性)。PANSS-6 与 PANSS-6 之间的 ICC 为 0.67[95%CI=0.56-0.76],反应性的 Spearman 等级相关系数为 0.40(=0.004)。当剔除特定的异常评估者的数据时,PANSS-6 与 PANSS-6 之间的 ICC 为 0.75[95%CI=0.63-0.83],反应性的 Spearman 等级相关系数为 0.55(=0.018)。

结论

我们发现 PANSS-6 评分具有可接受的临床有效性,表明 PANSS-6 可用于住院和门诊精神分裂症患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验